Electrowetting Microfluidic PCR Automation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid amplification methods lack efficient automation and real-time monitoring capabilities, particularly in microfluidic systems, which limits their ability to accurately quantify and recover amplification products for further analysis.

Innovation Solution

An electrowetting-based device with a biplanar configuration of parallel electrodes is used to automate nucleic acid amplification, allowing for real-time quantitation and recovery of amplification products through electrowetting-mediated droplet manipulations, thermocycling, and detection using DNA binding dyes or probes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Extent of automation

If manual nucleic acid amplification methods are used, then flexibility in experimental setup is maintained, but automation and real-time monitoring capabilities are lacking

Engineering Contradiction:
Improveautomation of nucleic acid amplificationVSAvoidcomplexity of microfluidic system
Core Design Contradiction:
Extent of automationVSDevice complexity

Solution Approach 1:

The system partitions the nucleic acid amplification process into discrete droplet units, each serving as an independent micro-reactor. This segmentation enables automated handling of multiple samples in parallel while maintaining manageable system complexity through modular architecture. The droplet-based compartmentalization allows standard microfluidic components to be used repeatedly across different amplification reactions.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The electrowetting-based microfluidic device performs multiple functions including droplet generation, thermocycling, real-time fluorescence detection, and product recovery within a single integrated platform. This multi-functionality reduces the need for separate manual operations and equipment, thereby increasing automation without proportionally increasing device complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If conventional amplification methods are used, then simplicity of procedure is maintained, but real-time quantitation and product recovery are limited

Engineering Contradiction:
Improvereal-time quantitation of amplification productVSAvoidspeed of amplification and detection
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The system implements continuous real-time fluorescence monitoring throughout the amplification process by integrating detection capabilities directly into the microfluidic chip. This allows uninterrupted quantitation of amplification products as they are generated, eliminating the need to stop the reaction for sampling and analysis, thereby maintaining both measurement precision and productivity.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

Fluorescence probes serve as intermediaries that enable real-time detection of amplification products without interfering with the PCR reaction. The probes bind to target sequences and emit fluorescent signals that can be detected through the microfluidic chip, providing continuous quantitation data while the amplification proceeds uninterrupted.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If manual liquid manipulation is used, then operator control is maintained, but errors associated with pipetting and human involvement increase

Engineering Contradiction:
Improveaccuracy of nucleic acid analysisVSAvoidlevel of automated droplet manipulation
Core Design Contradiction:
ReliabilityVSExtent of automation

Solution Approach 1:

The system replaces manual pipetting and mechanical liquid handling with electrowetting-based droplet manipulation. Electric fields control the movement, merging, and splitting of droplets containing nucleic acid samples and reagents. This substitution eliminates human error in liquid transfer while maintaining precise control over reaction conditions, thereby increasing reliability through automation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The electrowetting device automatically performs droplet generation, thermocycling, and product recovery without requiring manual intervention at each step. The system self-regulates the amplification process through programmed electrical signals that control heating elements and droplet manipulation, reducing operator errors while maintaining experimental control through software programming.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables rapid, efficient, and precise automation of nucleic acid amplification, allowing for real-time monitoring and recovery of amplification products, enhancing sensitivity and reducing errors in nucleic acid analysis.

Implementation Method 1

an electrowetting-based device to automate nucleic acid amplification and allow for the quantity of the nucleic acid amplification product to be monitored in real time

Methodology Applied
Scientific EffectElectrowetting: Electrowetting

Implementation Method 2

amplifying the target nucleic acid in each said droplet in parallel

Methodology Applied
Scientific EffectThermocycling:

Data Source

PatentEP3458597B1Quantitative real time PCR amplification using an electrowetting-based device
Publication Date: 2022.09.07 ROCHE DIAGNOSTICS GMBH
  • EP3458597B1 patent drawingFigure 1A~1B
  • EP3458597B1 patent drawingFigure 2A~2C
  • EP3458597B1 patent drawingFigure 3

AI summary

The present invention generally relates to a method which makes use of electrowetting to automate PCR amplification wherein the PCR reagents are contained in droplets, and further wherein the quantity of PCR product is monitored in real time thus enabling stopping amplification once a desired quantity of PCR product has been generated.